ClinicalTrials.Veeva

Menu

Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation

Henry Ford Health logo

Henry Ford Health

Status

Completed

Conditions

Left Atrial Appendage Occlusion
Cardiac Catheterization
Atrial Fibrillation
Heart Atria
Cardiac Surgical Procedures
Left Atrial Appendage Ligation
Pneumopericardium
Epicardial Mapping
Pericardium

Treatments

Procedure: Pericardial insufflation with carbon dioxide through a transatrial microcatheter

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

We use a tiny catheter through the heart to separate the pericardium with gas. We expect this to improve the safety of the Lariat procedure.

Full description

The Lariat suture device enables non-surgical exclusion of the left atrial appendage possibly to prevent thromboembolism and stroke in patients with atrial fibrillation. Subxiphoid needle access to the pericardium (a standard approach to enter the pericardial space surrounding the heart using a needle underneath the breastbone) during Lariat risks injury to the heart surface that requires surgical repair.

In this protocol the investigators propose test a new method to increase the safety of needle access to the pericardium. Before needle access, the investigators introduce a separate tiny catheter into the pericardium from inside the heart through a tiny hole. The investigators then inject gas to push the heart away from the pericardial needle. This reduces the risk of injuring the heart during the standard Lariat procedure.

Enrollment

13 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Undergoing subxiphoid access to the "empty" pericardial space as part of a Lariat left atrial appendage exclusion procedure
  • Age ≥ 21 years

Exclusion criteria

• Does not consent to participate

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

13 participants in 1 patient group

Pericardial insufflation with CO2
Experimental group
Description:
Intentional transatrial introduction of a microcatheter to insufflate the pericardium with carbon dioxide, to separate the walls of the pericardium
Treatment:
Procedure: Pericardial insufflation with carbon dioxide through a transatrial microcatheter

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems